Coherus Oncology, Inc.CHRSNASDAQ
Loading
Debt-to-equity ratio
5Y CAGR
-9.7%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.89 | +143.6% |
| 2024 | -2.04 | +17.7% |
| 2023 | -2.49 | +28.9% |
| 2022 | -3.50 | -181.5% |
| 2021 | 4.29 | +188.8% |
| 2020 | 1.48 | -17.2% |
| 2019 | 1.79 | +167.1% |
| 2018 | -2.67 | -180.4% |
| 2017 | 3.32 | -35.9% |
| 2016 | 5.18 | - |